458
Medicinal Chemistry Research (2021) 30:449–458
drug-resistant tuberculosis. Acta Crystallographica Section C.
2019;75:1031–5.
14. Richter A, Rudolph I, Möllmann U, Voigt K, Chung CW, Singh
OMP, et al. Novel insight into the reaction of nitro, nitroso and
hydroxylamino benzothiazinones and of benzoxacinones with
30. Zhang G, Howe M, Aldrich CC. Spirocyclic and bicyclic 8-
nitrobenzothiazinones for tuberculosis with improved physico-
chemical and pharmacokinetic properties. ACS Med Chem Lett.
2019;10:348–51.
31. Shaikh MH, Subhedar DD, Arkile M, Khedkar VM, Jadhav N,
Sarkar D, et al. Synthesis and bioactivity of novel triazole incor-
porated benzothiazinone derivatives as antitubercular and anti-
oxidant agent. Bioorg Med Chem Lett. 2016;26:561–9. https://doi.
32. Majewski MW, Tiwari R, Miller PA, Cho S, Franzblau SG,
Miller MJDesign. syntheses, and anti-tuberculosis activities of
conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs)
with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids
and 7-phenylacetyl cephalosporins. Bioorg Med Chem Lett.
33. Armenise D, Muraglia M, Florio MA, De Laurentis N, Rosato A,
Carrieri A, et al. 4H-1,4-benzothiazine, dihydro-1,4-benzothiazi-
nones and 2-amino-5-fluorobenzenethiol derivatives: design,
synthesis and in vitro antimicrobial screening. Archiv der Phar-
Mycobacterium
tuberculosis
DprE1.
Scientific
Rep.
15. Gao C, Peng C, Shi Y, You X, Ran K, Xiong L, et al. Ben-
zothiazinethione is a potent preclinical candidate for the treatment
of drug-resistant tuberculosis. Scientific Rep. 2016;6:1–9.
16. Gao C, Ye T-H, Wang N-Y, Zeng X-X, Zhang L-D, Xiong Y,
et al. Synthesis and structure–activity relationships evaluation of
benzothiazinone derivatives as potential anti-tubercular agents.
Bioorganic Med Chem Lett. 2013;23:4919–22.
̌
17. Tiwari R, Miller PA, Chiarelli LR, Mori G, Sarkan M, Centárová
I, et al. Design, syntheses, and anti-TB activity of 1, 3-
benzothiazinone azide and click chemistry products inspired by
BTZ043. ACS Med Chem Lett. 2016;7:266–70.
18. Li P, Wang B, Zhang X, Batt SM, Besra GS, Zhang T, et al.
Identification of novel benzothiopyranone compounds against
Mycobacterium tuberculosis through scaffold morphing from
benzothiazinones. Eur J Med Chem. 2018;160:157–70.
mazie.
2012;345:407–16.
̌
́
34. Tiwari R, Moraski GC, Krchnak V, Miller PA, Colon-Martinez
M, Herrero E, et al. Thiolates chemically induce redox activation
of BTZ043 and related potent nitroaromatic anti-tuberculosis
agents. J Am Chem Soc. 2013;135:3539–49.
̈
19. Karoli T, Becker B, Zuegg J, Mollmann U, Ramu S, Huang JX,
et al. Identification of antitubercular benzothiazinone compounds
by ligand-based design. J Med Chem. 2012;55:7940–4.
20. Lv K, Tao Z, Liu Q, Yang L, Wang B, Wu S, et al. Design,
synthesis and antitubercular evaluation of benzothiazinones con-
taining a piperidine moiety. Eur J Med Chem. 2018;151:1–8.
21. Lv K, Wang A, Tao Z, Fu L, Liu H, Wang B, et al. hERG opti-
mizations of IMB1603, discovery of alternative benzothiazinones
as new antitubercular agents. Eur J Med Chem. 2019;179:208–17.
22. Lv K, You X, Wang B, Wei Z, Chai Y, Wang B, et al. Identifi-
cation of better pharmacokinetic benzothiazinone derivatives as
new antitubercular agents. ACS Med Chem Lett. 2017;8:636–41.
23. Peng C-T, Gao C, Wang N-Y, You X-Y, Zhang L-D, Zhu Y-X,
et al. Synthesis and antitubercular evaluation of 4-carbonyl
piperazine substituted 1, 3-benzothiazin-4-one derivatives.
Bioorganic Med Chem Lett. 2015;25:1373–6.
35. Foo CS, Lechartier B, Kolly GS, Boy-Röttger S, Neres J, Rybniker
J, et al. Characterization of DprE1-mediated Benzothiazinone
resistance in mycobacterium tuberculosis. Antimicrobial Agents
36. Trefzer C, Škovierová H, Buroni S, Bobovská A, Nenci S, Mol-
teni E, et al. Benzothiazinones are suicide inhibitors of myco-
bacterial decaprenylphosphoryl-β-D-ribofuranose 2’-oxidase
37. Neres J, Pojer F, Molteni E, Chiarelli LR, Dhar N, Boy-Röttger S,
et al. Structural basis for benzothiazinone-mediated killing of
Mycobacterium tuberculosis. Sci Transl Med. 2012;4:150ra21.
24. Piton J, Vocat A, Lupien A, Foo CS, Riabova O, Makarov V et al.
Structure-based drug design and characterization of sulfonyl-
piperazine benzothiazinone inhibitors of DprE1 from Mycobacter-
ium tuberculosis. Antimicrobial Agents Chemother. 2018;62.
25. Tiwari R, Miller PA, Cho S, Franzblau SG, Miller MJ. Syntheses
and antituberculosis activity of 1, 3-benzothiazinone sulfoxide and
sulfone derived from BTZ043. ACS Med Chem Letters.
2015;6:128–33.
38. Fleming FF, Yao L, Ravikumar PC, Funk L, Shook BC. Nitrile-
containing Pharmaceuticals: efficacious roles of the nitrile phar-
39. Liu L, Kong C, Fumagalli M, Savková K, Xu Y, Huszár S, et al.
Design, synthesis and evaluation of covalent inhibitors of DprE1
as antitubercular agents. Eur J Med Chem. 2020;208:112773.
26. Wang A, Lv K, Tao Z, Gu J, Fu L, Liu M, et al. Identification of
benzothiazinones containing an oxime functional moiety as new
anti-tuberculosis agents. Eur J Med Chem. 2019;181:111595.
27. Xiong L, Gao C, Shi Y-J, Tao X, Peng C-T, Rong J et al.
Metabolism of SKLB-TB1001, a potent antituberculosis agent, in
animals. Antimicrobial Agents Chemother. 2018;62.
40. Richter A. Synthese von benzothiazinonen und derivaten als
DprE1 hemmstoffe mit antimykobakterieller Aktivität. Martin-
Luther-Universität Halle-Wittenberg: Germany, 2017.
41. Zhang G, Aldrich CC. Macozinone: revised synthesis and crystal
structure of a promising new drug for treating drug-sensitive and
drug-resistant tuberculosis. Acta crystallographica Section C.
28. Xiong L, Gao C, Shi Y-J, Tao X, Rong J, Liu K-L, et al. Iden-
tification of a new series of benzothiazinone derivatives with
excellent antitubercular activity and improved pharmacokinetic
profiles. RSC Adv. 2018;8:11163–76.
29. Zhang R, Lv K, Wang B, Li L, Wang B, Liu M, et al. Design,
synthesis and antitubercular evaluation of benzothiazinones con-
taining an oximido or amino nitrogen heterocycle moiety. RSC
Adv. 2017;7:1480–3.
Struct
Chem.
2019;75:1031–5.
42. Makarov AV, Cole ST, Möllmann U. New benzothiazinone
derivatives and their use as antibacterial agents. Google Patents,
2011.
43. Leeson PD, Springthorpe B. The influence of drug-like concepts
on decision-making in medicinal chemistry. Nat Rev Drug Dis-
cov. 2007;6:881–90.